Full Press Release Details
linvoseltamab in combination with carfilzomib or bortezomib shows promising initial results in earlier lines of treatment for relapsed refractory multiple myeloma.
REGN
linvoseltamab in combination with carfilzomib or bortezomib shows promising initial results in earlier lines of treatment for relapsed refractory multiple myeloma
Key Takeaway: linvoseltamab in combination with carfilzomib or bortezomib shows promising initial results in earlier lines of treatment for relapsed refractory multiple myeloma